Rhumbline Advisers SPYRE THERAPEUTICS INC Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
Number of Shares
53,935
Previous 51,896
3.93%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%